BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 30/10/2017

FDA Classifies Non-EEG Seizure Monitoring System into Class II with Special Controls

The FDA has classified the non-electroencephalogram physiological signal based seizure monitoring system into Class II, requiring special controls to ensure safety and effectiveness, aiming to enhance patient access to innovative devices and reduce regulatory burdens.

Source: Federal Register — Food and Drug AdministrationOpen original release →